Login to Your Account

CUP of liquid biopsy

Researchers use liquid biopsy to find treatable mutations for rare cancer patients

By Stacy Lawrence
Staff Writer

Thursday, August 17, 2017

One criticism of genetic approaches to cancer treatment has been that they don't actually improve care for most patients. But as the number of targeted drugs has expanded exponentially as part of the ongoing cancer immunotherapy push and genetic research has advanced, that may no longer be the case.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription